Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

44%

4 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 2

3(37.5%)

Phase 3

3(37.5%)

N/A

1(12.5%)

Phase 4

1(12.5%)

8Total

Phase 2(3)

Phase 3(3)

N/A(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT05086679Not ApplicableUnknown

Compression Stockings for Treating Vasovagal Syncope Trial

Role: collaborator

NCT04486508Phase 3Completed

Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19

Role: collaborator

NCT04595942Phase 3Unknown

Midodrine and Fludrocortisone for Vasovagal Syncope

Role: collaborator

NCT01820195Phase 3Unknown

N-Acetyl Cystein and Contrast Nephropathy

Role: lead

NCT01410617Phase 2Unknown

The Effect of Prophylactic Hemodialysis on the Morbidity and Mortality of the Patients With Chronic Kidney Disease Stages 3-4 Undergoing Coronary Artery Graft Bypass

Role: lead

NCT01359345Phase 2Unknown

Nephrogenic Systemic Fibrosis With Gadollinum

Role: lead

NCT00656695Phase 4Completed

Comparisone of Iminoral Versus Neoral in Prevention of Acute Rejection in Renal Transplantation

Role: lead

NCT00885768Completed

Prevalence of Renal Artery Stenosis in Patients Referred for Cardiac Catheterization

Role: lead

NCT01195233Phase 2Completed

Comparative Analysis of BioXtra on Xerostomia

Role: collaborator

All 9 trials loaded